絞り込み

16403

広告

Clinical conundrums in antithrombotic therapy management: A Delphi Consensus panel.

著者 Colonna P , Andreotti F , Ageno W , Pengo V , Marchionni N
Int J Cardiol.2017 Sep 19 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (19view , 0users)

Full Text Sources

Miscellaneous

Anticoagulants are recommended for the prevention of stroke/systemic embolism for most patients with atrial fibrillation (AF) and for the treatment of patients with venous thromboembolism (VTE). Regulatory-driven randomized trials, however, typically exclude extreme patient scenarios involving, for instance, severe bleeding, ischaemic risk, frailty or renal impairment, despite their common occurrence in clinical practice. Uncertainty in the management of such cases leads to a high degree of variability in therapeutic approaches. Consensus conferences or panels may provide insights and help bridge the gaps that separate clinical guidelines from real-world practice. In the present study, a description of challenging AF and VTE patients was submitted to a large panel of experts to investigate areas of common or divergent management.
PMID: 28970039 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード